Godfred Otchere | Public Health | Best Researcher Award

Dr. Godfred Otchere | Public Health | Best Researcher Award

University of Otago,  New Zealand

Mr. Godfred Otchere is a Ghanaian public and global health researcher and doctoral candidate at the University of Otago, Medical School, New Zealand. With over six years of experience in research, healthcare planning, and statistical analysis, he has contributed to diverse projects addressing critical healthcare challenges in Ghana and beyond. His academic and professional journey reflects a strong commitment to improving health systems, policy, and education. Godfred has held several positions at Komfo Anokye Teaching Hospital, including Biostatistician, Health Planner, and Research Assistant on the Sugar Talk project. He has published seven peer-reviewed journal articles in global health systems, malaria prevention, hepatitis B awareness, and diabetes self-management. He is a recipient of prestigious awards, including the University of Otago Doctoral Scholarship, DAAD Scholarship, and Laura Bassi Scholarship. Through his research in population health and health promotion, Godfred aims to influence policy and improve community health outcomes across developing countries.

Professional Profile

Education

Godfred Otchere holds a Master of Science degree in Global Health from the University of Freiburg, Germany (2021–2022), where he gained interdisciplinary training in international health issues, policy, and research. He earned a Bachelor of Science in Management with First Class Honours from the University of Education, Winneba-Ghana (2013–2017), demonstrating academic excellence in business administration and health service management. His foundational education includes a West Africa Senior School Certificate Examination (WASSCE) in Business Accounting from Swedru School of Business, Ghana (2008–2012), which provided him with a solid background in accounting, finance, and administration. His academic achievements are marked by his continuous pursuit of excellence and his selection for prestigious scholarships, including DAAD and Laura Bassi. Currently, he is pursuing a PhD at the University of Otago, focusing on health systems, policy, and public health research. His educational background combines business acumen with health science, equipping him for complex health system challenges.

Professional Experience

Godfred Otchere has six years of experience in public health research, planning, and administration, primarily at Komfo Anokye Teaching Hospital in Ghana. From 2018 to 2021, he served as Health Planner and Administrative Manager in the Policy, Planning, Monitoring and Evaluation Unit, where he developed and implemented strategies for hospital performance improvement. Simultaneously, he worked as a Research Assistant on the Sugar Talk project, addressing diabetes management and patient education. During his National Service (2017–2018), he functioned as a Biostatistician in various hospital units, including Oncology, Family Planning, and Psychiatry, gaining hands-on experience in healthcare data analysis and clinical support. Currently, he is a doctoral candidate at the University of Otago, focusing on health systems and population health. His combined research and administrative experience informs his approach to health policy, systems strengthening, and health education, especially in resource-limited settings. He is also a published author in several peer-reviewed journals.

Research Interests

Godfred Otchere’s research focuses on population health, health systems and policy, public and global health, and health education and promotion. He is passionate about improving healthcare delivery and patient outcomes in low-resource settings through evidence-based research. His doctoral research at the University of Otago examines system-level health interventions and the impact of policy on population health outcomes. Godfred has contributed to projects exploring diabetes education, hepatitis B awareness, malaria prevention, and healthcare quality improvement strategies. His work often involves interdisciplinary methods, including policy analysis, health promotion models, and stakeholder engagement. Through systematic reviews, surveys, and field studies, he aims to bridge the gap between healthcare research and practice. His published work, including scoping reviews and protocol development, reflects a strong emphasis on practical solutions for healthcare challenges in Ghana and similar contexts. Godfred’s ultimate goal is to influence global health policy and empower communities through informed, sustainable public health interventions.

Awards and Honors

Godfred Otchere has been recognized with several prestigious awards for his academic and research excellence. He is a current recipient of the University of Otago Doctoral Scholarship (2023–2026), awarded for outstanding doctoral research potential. He was also awarded the DAAD Scholarship (2021/2022) for his Master’s studies in Global Health at the University of Freiburg, reflecting his international academic merit. In 2022, he received the Laura Bassi Scholarship, which supports junior researchers undertaking impactful academic work, demonstrating both promise and commitment to advancing public health research. He graduated with First Class Honours in Management from the University of Education, Winneba-Ghana in 2017, underscoring his consistent academic excellence. These distinctions highlight Godfred’s dedication to scholarship, leadership in health research, and commitment to addressing global health challenges. His awards reflect his potential to contribute significantly to policy-making and sustainable health interventions in developing and underserved populations.

Publications

  • Diabetes self-management education interventions in the WHO African Region: A scoping review
    E Kumah, G Otchere, SE Ankomah, A Fusheini, C Kokuro, K Aduo-Adjei, …
    PloS one 16 (8), e0256123
  • Influence of the Model of Care on the Outcomes of Diabetes Self‐Management Education Program: A Scoping Review
    E Kumah, EK Afriyie, AA Abuosi, SE Ankomah, A Fusheini, G Otchere
    Journal of diabetes research 2021 (1), 2969243
  • Intermittent preventive treatment of Malaria in pregnancy with sulphadoxine-pyrimethamine and its Associated factors in the Atwima Kwanwoma District, Ghana
    E Kumah, F Duvor, G Otchere, SE Ankomah, A Fusheini, C Kokuro, …
    Annals of global health 88 (1), 27
  • Quality improvement in healthcare: A focus on patient focused strategies
    E Kumah, SE Ankomah, SK Agyei, G Otchere
    International Journal of Biosciences, Healthcare Technology and Management 9 …
  • Framework for assessing the performance of the Ghanaian health system: study protocol
    E Kumah, SE Ankomah, A Fusheini, P Agyei-Baffour, MA Ayanore, …
    Health research policy and systems 19, 1-8
  • Knowledge, attitude and practice towards hepatitis B infection among high school students in Asante Mampong, Ghana
    G Otchere, E Dwomoh, E Kumah, SE Ankomah, A Fusheini, …
    International Journal of Risk & Safety in Medicine 33 (3), 269-279
  • Factors influencing community acceptability of mass drug administration for the elimination of onchocerciasis in the Asante Akim South Municipal, Ghana
    E Kumah, P Owusu, G Otchere, SE Ankomah, A Fusheini, C Kokuro, …
    PLoS neglected tropical diseases 17 (3), e0011251

 

 

 

Junjie Liu | pharmaceutics | Best Researcher Award

Prof. Junjie Liu | pharmaceutics | Best Researcher Award

professor, Zhengzhou University, China

Liu Junjie is a professor and PhD supervisor at the School of Pharmacy, Zhengzhou University. 🎓 He completed his PhD in pharmaceutical sciences from Chongqing University in 2018. 📚 With over 40 publications in top journals like Sci Adv and Adv Mater, he is a recognized leader in his field. 🧬 He has led 10 major research projects, including grants from the National Natural Science Foundation of China. 🌍 Liu has received multiple prestigious honors, including youth talent support and high-level talent awards. 🚀 His contributions in pharmaceutical science are shaping the future of health and medicine.

Education🎓 

Liu Junjie obtained his PhD in pharmaceutical sciences from Chongqing University in 2018. 🏫 His advanced training in pharmaceutical sciences allowed him to develop expertise in drug development and pharmaceutical research. 📑 His education combined rigorous theoretical knowledge and hands-on experience in the laboratory, equipping him with the tools necessary for groundbreaking research. 🧪 He also pursued further professional development through leading postdoctoral research, continuously building on his PhD training. 💡 His academic foundation serves as the cornerstone for his innovative work in drug discovery and therapeutic development.

Experience🧑‍🏫 

Liu Junjie is currently a professor and PhD supervisor at Zhengzhou University’s School of Pharmacy. 🔬 He has extensive experience leading pharmaceutical research and managing collaborative research projects. 🧑‍🔬 Since completing his PhD, he has overseen 10 major research projects, including those supported by the National Natural Science Foundation of China. 🌟 His work has been featured in over 40 SCI-indexed publications as the first or corresponding author, showcasing his strong research output. 🌿 Liu is also actively involved in mentorship, guiding PhD students and shaping the next generation of pharmaceutical scientists.

Awards and Honors🏆

Liu Junjie has received numerous prestigious awards for his contributions to pharmaceutical research. 🎖️ Notably, he has been recognized by the China Association for Science and Technology with the Youth Talent Support award. 🌟 His high-level talent and innovative contributions to the field have earned him recognition in Henan Province, where he received the High-level Talent Award and was named an Outstanding Youth Talent in the Central Plains. 💼 Additionally, he was awarded the Innovative Talent Award for his role in advancing pharmaceutical research at Henan’s Higher Education Institutions.

Research Focus🔬 

Liu Junjie’s research focuses on the development of innovative drugs and therapeutic treatments. 🧪 His work aims to bridge the gap between basic pharmaceutical sciences and clinical applications, exploring drug delivery systems and novel therapeutic materials. 🧬 He is particularly interested in precision medicine and the design of targeted therapies to improve treatment efficacy and minimize side effects. 🌍 His interdisciplinary research integrates chemistry, biology, and materials science to advance drug development, leading to over 40 high-impact publications in renowned scientific journals. 📈 His research aims to transform healthcare and patient outcomes.

Publication Top Notes

In situ implantable DNA hydrogel for diagnosis and therapy of postoperative rehemorrhage following intracerebral hemorrhage surgery

Published in: Science Advances (2024, 10(33), ado3919)
Authors: Yu, W., Gong, E., Wang, C., Liu, J., Shi, J.
Overview: This research focuses on a DNA hydrogel that can be implanted in situ to diagnose and treat rehemorrhage after intracerebral hemorrhage surgery, providing a new tool for post-surgical care.

2. In situ formation of biohybrid system based on Streptococcus pneumoniae for enhanced radical therapy against tumors

Published in: Cell Reports Physical Science (2024, 5(7), 102074)
Authors: Zhao, X., Wang, Q., Dong, H., Liu, J., Shi, J.
Overview: The study explores a biohybrid system using Streptococcus pneumoniae for improved radical cancer therapies, targeting tumors more effectively.

3. Retraction Note: Copper-based metal-organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade

Published in: Journal of Nanobiotechnology (2024, 22(1), pp. 302)
Authors: Wang, S., Yin, N., Li, Y., Si, P., Liu, J.
Overview: This article was retracted, but it originally examined how copper-based frameworks prevent breast cancer metastasis by blocking estrogen and platelets.

4. A Neutrophil Hijacking Nanoplatform Reprograming NETosis for Targeted Microglia Polarizing Mediated Ischemic Stroke Treatment

Published in: Advanced Science (2024, 11(17), 2305877)
Authors: Yin, N., Wang, W., Pei, F., Wang, Z.-H., Liu, J.
Overview: The research proposes a nanoplatform that hijacks neutrophils to treat ischemic stroke by modulating microglia polarization.

5. Ultrasensitive Optical Detection and Elimination of Residual Microtumors with a Postoperative Implantable Hydrogel Sensor for Preventing Cancer Recurrence

Published in: Advanced Materials (2024, 36(14), 2307923)
Authors: Geng, S., Guo, P., Wang, J., Shi, J., Liu, J.
Overview: This article focuses on an optical sensor integrated with a hydrogel to detect and remove microtumors post-surgery, reducing cancer recurrence risk.

6. Biomimetic Nanovehicle-Enabled Targeted Depletion of Intratumoral Fusobacterium nucleatum Synergizes with PD-L1 Blockade against Breast Cancer

Published in: ACS Nano (2024, 18(12), pp. 8971–8987)
Authors: Geng, S., Guo, P., Li, X., Liu, J., Yang, Y.
Overview: This study examines a nanovehicle that targets Fusobacterium nucleatum within tumors to boost the effectiveness of PD-L1 blockade therapies for breast cancer.

Conclusion

Liu Junjie is an excellent candidate for the Best Researcher Award. His robust academic output, leadership in research projects, mentorship, and numerous recognitions make him well-suited for this prestigious recognition. While expanding his international collaborations and increasing the practical application of his research could further enhance his candidacy, his contributions to pharmaceutical sciences and his leadership in innovative research projects make him a strong contender for this award.